Marshall Wace’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Marshall Wace’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-3,543	Closed	-$420K	–	3529
2021 Q1	$420K	Sell	3,543 -27,337	-89%	-$3.23M	﹤0.01%	2010
2020 Q4	$3.65M	Sell	30,880 -77,288	-71%	-$8.98M	0.02%	689
2020 Q3	$12M	Sell	108,168 -60,150	-36%	-$6.46M	0.08%	254
2020 Q2	$17.2M	Buy	+168,318	New	+$18M	0.12%	181
2020 Q1	–	Sell	-368	Closed	-$43K	–	2289
2019 Q4	$43K	Sell	368 -64,392	-99%	-$7.46M	﹤0.01%	1556
2019 Q3	$7.41M	Buy	+64,760	New	+$6.44M	0.06%	380

Marshall Wace's CBPO Position: Q2 2021 in Review

Marshall Wace sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 3,543 shares — an estimated $420K sold.

Marshall Wace first reported a position in CBPO in Q3 2019 and held it in 6 quarters. The position peaked at $17.2M in Q2 2020. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

Marshall Wace reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 3,543 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $420K.
Marshall Wace first reported a position in China Biologic Products Holdings, Inc. in Q3 2019 and held it in 6 quarters.
Marshall Wace's China Biologic Products Holdings, Inc. position peaked at $17.2M in Q2 2020.
0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.